References
- Sugiura H, Matsubayashi T. Clinical features of CINCA syndrome: Effects and problems of IL-1Ra (in Japanese). Nihon Rinsho Meneki Gakkai Kaishi. 2007;30(2):108–13.
- Aoyama K, Amano H, Takaoka Y, Nishikomori R, Ishikawa O. Cryopyrin-associated periodic syndrome: A case report and review of the Japanese literature. Acta Derm Venereol. 2012;92(4):395–8.
- Jasmin BK, Eduardo R, Norbert B, Joachim R, Sandra DF, Thomas J, et al. Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS). Arthritis Res Ther. 2011;13(1):R34. doi: 10.1186/ar3266.
- Walshe MM, Warin RP. Syndrome of prolonged history of evanescent blotchy urticaria associated with arthritis, hepatosplenomegaly and lymphadenopathy(Still's disease). Proc R Soc Med. 1963;56(10):905–6.
- Goldbach-Mansky R. Current status of understanding the pathogenesis and management of patients with NOMID/CINCA. Curr Rheumatol Rep. 2011;13(2):123–31.
- Miyamae T, Inaba Y, Nishimura G, Kikuchi M, Kishi T, Hara R, et al. Effect of anakinra on arthopathy in CINCA/NOMID syndrome. Pediatr Rheumatol Online J. 2010;8:6. doi: 10.1186/1546-0096-8-9.
- Kuemmerle-Deschner JB, Tyrrell PN, Koetter I, Wittkowski H, Bialkowski A, Tzaribachev N, et al. Efficacy and safety of Anakinra therapy in pediatric and adult patients with autoinflammatory Muckle-Wells syndrome . Arthritis Rheum. 2011;63(3):840–9.
- Sibley CH, Plass N, Snow J, Wiggs EA, Brewer CC, King KA, et al. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes . Arthritis Rheum. 2012;64(7):2375–86.
- Goodman SM, Fiffie M. Lower extremity arthroplasty in patients with inflammatory arthrisis: Preoperative and perioperative managemant. J Am Acad Othop Surg. 2013;21(6):355–63.
- Tanaka N, Izawa K, Saito MK, Sakuma M, Oshima K, Ohara O, et al.High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: Results of an international multicenter collaborative study. Arthritis Rheum. 2011;63(11):3625–32.
- Caorsi R, Lepore L, Zulian F, Alessio M, Stabile A, Insalaco A, et al. The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age . Arthritis Res Ther. 2013;15(1):R33. doi: 10.1186/ar4184.
- Kone-Paut I, Lachmann HJ, Kuemmerle-Deschner JB, Hachulla E, Leslie KS, Mouy R, et al. Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: Results of a double-blind placebo-controlled randomized withdrawal study . Arthritis Res Ther. 2011;13(6):R202. doi: 10.1186/ar3535.
- Simon S, Whiffen J, Shapiro F. Leg-length discrepancies in monoarticular and pauciarticular juvenile rheumatoid arthritis. J Bone Joint Surg Am. 1981;63(2):209–15.
- Sherry DD, Stein LD, Reed AM, Schanberg LE, Kredich DW. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. Arthritis Rheum.1999;42(11):2330–4.
- Rydholm U, Brattstrom H, Bylander B, Lidgren L. Stapling of the knee in juvenile chronic arthritis. J Pediatr Orthop. 1987;7(1):63–8.
- Posch C, Kaulfersch W, Rappersberger K. Cryopyrin-Associated Periodic Syndrome. Pediatr Dermatol. 2014;31(2):228–31. doi: 10.1111/j.1525–1470.2012.01812.x.